Application Notes

Cellastim S – Reconstitution Application Note

AAV Production – How To Improve Transfection Efficiency and Titer Yield

Exbumin – Stabilizing Virus with Albumin to Improve Yield Application Note

Lentrivirus Production Protocol in Serum-Free Conditions – How To Improve Transfection Efficiency and Titer Yield

Blog

Explore the Latest Developments in T-reg Research and Clinical Application

High-Performance Production of Viral Vectors for Cell and Gene Therapy Using OptiPEAK HEK293t Complete Media

InVitria Expands European and UK Footprint

The Emergence of Serum-Free Cell Culture Media – Blood-Free Chemically Defined Components

Interviews

Blood-Free Fetal Bovine Serum Alternatives in Cell Culture Media

Posters

Adherent HEK293t Cells Cultured in Pall’s iCELLis® Bioreactor with OptiPEAK HEK293t Blood-Free Chemically Defined Media Exhibit Robust and Rapid Population Doubling Times

Chemically Defined iCELLis® Bioreactor-Based Lentiviral Vector Mass Production

Chemically Defined iCELLis® Bioreactor-Based Viral Vector Manufacturing – Application of Aber Biomass Probes to Inform Transfection Timing

Improving Vaccine Development, Performance, and Stability with Recombinant HSA Excipient

Product Brochures

2021 Product Catalog

ITSE AF – Brochure

Optiferrin – Product Brochure

Product Specifications

ITS – Specifications

OptiPEAK HEK293t – Product Specifications

SDS

ITSE AF – Safety Data Sheet

OptiPEAK HEK293t – Safety Data Sheet

Use Guidelines

Cellastim S – Guidelines for Use

ITS – Guidelines for Use

ITSE AF – Guidelines for Use

ITSE+A – Guidelines for Use

Optiferrin – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

White Papers

Emergence of Blood-Free Recombinant Human Albumin

Formulation and production of a blood‐free and chemically defined virus production media for VERO cells

Process Optimization for Lentivirus Production in the iCELLis® Nano Using a Chemically Defined, Animal Component Free HEK293 Media